Lamictal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels, which stabilises neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This action diminishes neuronal hyper‑excitability, helping to control seizures and providing mood‑stabilising effects.

The dosage of Lamictal is individualized. A prescriber determines the starting dose and titration schedule based on the patient’s age, indication, renal and hepatic function, and concomitant medications. Patients should follow the specific instructions provided by their healthcare professional.

The safety of lamotrigine during pregnancy and lactation is not fully established. It is classified as pregnancy category unknown. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their physician before using Lamictal.

To order Lamictal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine, lamotrigine has a lower risk of drug‑induced hyponatremia and fewer cognitive side effects, but it requires careful titration to minimise rash risk. Its broad spectrum covers both focal and generalized seizures, and it also offers mood‑stabilising benefits not seen with many other antiepileptics.

Lamictal tablets should be stored at ambient temperature below 25 °C, in the original container, protected from moisture and direct sunlight. Keep the medication out of reach of children and do not use it after the expiry date printed on the packaging.

Lamictal is taken orally as a tablet. It should be swallowed whole with a glass of water, preferably with food to reduce gastrointestinal upset. The tablet should not be crushed, chewed, or split unless specifically instructed by a healthcare professional.

The most serious adverse reactions include severe skin conditions such as Stevens‑Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), as well as blood dyscrasias like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts. Immediate medical attention is required if any of these symptoms appear.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with severe hepatic impairment should avoid use, and those with a history of severe rash or SJS/TEN should not be re‑exposed. Pregnant or breastfeeding women should only use it after thorough risk‑benefit assessment by a physician.